시장보고서
상품코드
1993888

게놈 의료 시장 : 유형별, 용도별, 기술별, 컴포넌트별, 최종사용자별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율, 예측(2026-2033년)

Genomic Medicine Market, By Type, By Application, By Technology, By Component, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

발행일: | 리서치사: 구분자 AnalystView Market Insights | 페이지 정보: 영문 328 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




가격
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.
US $ 3,250 금액 안내 화살표 ₩ 4,876,000
PDF (5 User License) help
PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,650 금액 안내 화살표 ₩ 6,976,000
PDF & Excel (Enterprise User License) help
PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,650 금액 안내 화살표 ₩ 8,477,000
카드담기
※ 부가세 별도
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

게놈 의료 시장 규모는 2025년에 359억 8,498만 달러로 평가되며, 2026-2033년에 CAGR 16.35%로 확대할 것으로 전망되고 있습니다.

유전체 의학은 개인의 유전자(DNA) 정보를 활용하여 질병의 예방, 진단, 치료를 보다 효과적으로 수행하기 위한 현대적 헬스케어 접근법입니다. 사람마다 고유한 유전자 구성을 가지고 있으므로 이러한 유전적 차이를 연구함으로써 의료진은 왜 특정 사람이 특정 질병에 드는지 또는 치료에 대한 반응이 다른지 이해할 수 있습니다. 유전 데이터를 분석함으로써 의사는 질병의 위험을 조기에 파악하여 각 환자에게 더 적합한 치료를 제공할 수 있습니다. 이 접근법은 특히 암 치료, 희귀질환 진단, 적절한 약물 선택 등 분야에서 보다 개인화된 의료 서비스를 지원할 수 있습니다.

전 세계에서 볼 때, 각국 정부가 보건의료 성과 향상을 위해 국가 게놈 구상을 추진하면서 게놈 의료의 도입이 확대되고 있습니다. 예를 들어 영국 정부가 지원하는 'Genomics England' 프로그램에서는 '10만 게놈 프로젝트'를 통해 희귀질환과 암을 앓고 있는 약 8만 5,000명의 환자로부터 10만 건 이상의 유전체 염기서열 해독이 이루어졌다. 이러한 정부 주도의 노력은 게놈 연구 인프라를 강화하고 현대 의료 시스템에서 게놈 기술의 임상 적용을 가속화하고 있습니다.

게놈 의료 시장 - 시장 역학

시장 확대를 가속화하는 정밀의료(정밀의료)의 확산

정밀의료의 통합이 진행되고 있는 것이 게놈 의료 시장의 발전에 크게 기여하고 있습니다. 이 접근법에서는 개인의 유전적 특성, 생활습관, 환경적 영향을 고려한 치료 전략 개발에 중점을 두고 있습니다. 게놈 시퀀싱과 분자 진단 기술의 발전으로 의료진은 질병의 메커니즘에 대한 더 깊은 지식을 얻고, 더 적절한 치료법을 선택할 수 있게 되었습니다. 의료 서비스 제공자가 개인 맞춤형 치료 모델을 점점 더 많이 채택함에 따라 게놈 분석 및 유전자 검사에 대한 수요는 계속 확대되고 있습니다. 또한 정부 주도의 게놈 관련 구상이 맞춤형 의료로의 전환을 촉진하고 있습니다. 예를 들어 영국 보건사회부는 NHS 잉글랜드 게놈 의료 서비스를 통해 게놈 프로그램을 지원하고 있으며, 2023년까지 80만 건 이상의 게놈 검사를 실시하여 암 및 희귀 유전성 질환의 진단을 지원함으로써 정밀의료에 기반한 헬스케어 제공을 강화하고 있습니다.

정부 주도의 노력과 더불어 생명공학 기업도 맞춤형 의료의 연구개발과 임상 도입을 지원하기 위해 게놈 기술을 확대하고 있습니다. 예를 들어 BGI Genomics는 임상 진단, 생식 건강 검진 및 질병 연구에 사용되는 자사의 게놈 플랫폼을 통해 전 세계에서 수천만 건의 시퀀싱 검사를 처리했다고 보고했습니다. 이러한 대규모 게놈 검사 능력은 유전적 변이 및 바이오마커를 식별하고, 의료진과 연구자들이 표적 치료 및 맞춤형 치료 전략을 개발할 수 있도록 지원하며, 정밀의료의 광범위한 보급을 촉진하고 있습니다.

게놈 의료 시장 - 시장 세분화 분석:

글로벌 게놈 의료 시장은 유형, 응용 분야, 기술, 구성 요소, 최종사용자, 지역별로 세분화되어 있습니다.

유형별로는 진단용 유전체 의학이 다양한 질병과 관련된 유전적 변이를 식별하는 데 중요한 역할을 하고 있으므로 헬스케어 시장의 주요 부문이 될 것으로 예상됩니다. 의료 시스템에서 게놈 시퀀싱 및 분자 진단 기술의 채택이 확대됨에 따라 임상의들이 유전성 질환, 희귀 질환 및 암을 조기에 발견할 수 있는 능력이 향상되고 있습니다. 또한 진단용 유전체 툴은 개인별 맞춤 치료 전략을 가능하게 함으로써 보다 정확한 임상적 판단을 돕습니다. 예를 들어 영국 국민보건서비스(NHS)는 'NHS 게놈 의료 서비스'를 설립하고 2024년까지 81만 건 이상의 게놈 검사를 시행했습니다. 여기에는 7,000개 이상의 희귀질환 및 200개 이상의 암 적응증에 대한 검사가 포함되어 있습니다. 이러한 임상 적용의 확대는 조기 진단을 개선하고 전 세계 정밀의료 전략을 지원하는 데 있으며, 진단용 게놈 의료의 중요성이 커지고 있음을 보여줍니다.

구성요소별로 보면 이 시장은 장비, 소모품, 소프트웨어 및 서비스 등 3가지로 분류됩니다. 소모품은 시퀀싱 및 게놈 검사 워크플로우에서 지속적으로 사용되므로 시장의 대부분을 차지할 것으로 예상됩니다. 시약, 시퀀싱 키트, 플로우셀 등의 소모품은 모든 게놈 실험과 진단 검사에 필요한 소모품으로, 연구소 및 연구기관 전반에서 지속적인 수요를 창출하고 있습니다. 예를 들어 Illumina는 2023년 자사의 시퀀싱 소모품이 약 39억 달러의 매출을 기록했다고 보고했는데, 이는 게놈 연구와 임상 진단에 시약과 키트가 광범위하게 활용되고 있음을 반영합니다. 이러한 일관된 사용 현황은 대규모 게놈 검사 및 정밀 의료 응용을 지원하는 데 있으며, 소모품이 얼마나 중요한지 잘 보여줍니다.

게놈 의료 시장 - 지역별 인사이트

글로벌 게놈 의료 시장은 헬스케어 인프라의 발전, 게놈 연구 구상의 증가, 정밀 의료를 장려하는 정부 정책에 힘입어 여러 지역에서 꾸준히 성장하고 있습니다. 그 중에서도 북미는 탄탄한 제도적 기반과 게놈 혁신에 대한 지속적인 투자로 인해 계속해서 중요한 위치를 차지하고 있습니다. 정부 기관과 연구기관은 게놈 시퀀싱, 데이터 통합 및 개인 맞춤형 치료 접근법을 적극적으로 추진하고 있습니다. 예를 들어 미국 국립보건원(NIH)은 'All of Us' 조사 프로그램을 도입했습니다. 이는 100만 명 이상의 참여자로부터 건강 및 유전 정보를 수집하여 정밀 의료 연구를 지원하고 개인 맞춤형 헬스케어 전략을 개선하는 것을 목표로 하고 있습니다.

북미 지역에서 미국은 정부 및 산업계의 노력을 통해 게놈 의료의 발전에 중요한 역할을 하고 있습니다. 미국 국립보건원(NIH)에 따르면 국가 정밀의료 구상에 따라 이미 수십만 명의 참여자로부터 게놈 데이터세트가 생성되어 질병 연구개발을 지원하고 있습니다. 또한 일루미나, 써모피셔 사이언티픽과 같은 생명공학 기업은 게놈 시퀀싱 기술 및 분자 진단 솔루션을 지속적으로 확장하고 있습니다. 예를 들어 Illumina는 자사의 시퀀싱 플랫폼이 전 세계 게놈 데이터의 대부분을 생성하는 데 사용되고 있으며, 전 세계 연구기관, 병원 및 국가 게놈 프로젝트를 지원하고 있다고 보고했습니다. 이러한 정부 프로그램과 산업계의 발전은 종합적으로 미국의 리더십을 강화하고 세계 게놈 의료 시장에서 북미의 영향력을 높이고 있습니다.

일본 게놈 의료 시장 - 국가별 인사이트

일본에서는 정부의 강력한 정밀의료 및 유전체 연구 추진에 힘입어 유전체 의료 시장이 꾸준히 확대되고 있습니다. 후생노동성은 특히 암 진단과 치료에서 유전정보를 임상 진료에 통합하는 것을 목표로 하는 전국적인 게놈 프로그램을 지원해 왔습니다. 또한 일본 의료연구개발기구(AMED)는 질병 예방 및 개인 맞춤형 치료 향상을 위한 대규모 게놈 연구 프로젝트에 지속적으로 자금을 지원하여 일본의 게놈 의료 생태계를 강화하고 있습니다.

또한 일본은 희귀 유전성 질환의 진단 정확도 향상을 목적으로 AMED의 지원을 받는 '희귀-미진단 질환 구상(IRUD)' 등 국가 게놈 구상을 시행하고 있습니다. 정부 프로그램 최신 정보에 따르면 이 구상은 임상 진단 및 연구를 지원하기 위해 수만 명의 환자에서 얻은 게놈 데이터를 분석했다고 합니다. 또한 일본 정부는 게놈 데이터 공유와 첨단 의료 연구 인프라 구축을 지속적으로 추진하고 있으며, 이를 통해 국내 헬스케어 시스템에서 게놈 의료의 보급과 혁신을 촉진할 수 있을 것으로 기대됩니다.

목차

제1장 게놈 의료 시장 개요

제2장 개요

제3장 게놈 의료의 주요 시장 동향

제4장 게놈 의료 산업 분석

제5장 게놈 의료 시장 : 높아지는 지정학적 긴장의 영향

제6장 게놈 의료 시장 구도

제7장 게놈 의료 시장 : 유형별

제8장 게놈 의료 시장 : 용도별

제9장 게놈 의료 시장 : 기술별

제10장 게놈 의료 시장 : 컴포넌트별

제11장 게놈 의료 시장 : 최종사용자별

제12장 게놈 의료 시장 : 지역별

제13장 주요 벤더 분석 : 게놈 의료 산업

제14장 애널리스트의 전방위 전망

KSA 26.04.28

Genomic Medicine Market size was valued at US$ 35,984.98 Million in 2025, expanding at a CAGR of 16.35% from 2026 to 2033.

Genomic medicine is a modern healthcare approach that uses information from a person's genes (DNA) to help prevent, diagnose, and treat diseases more effectively. Since every individual has a unique genetic makeup, studying these genetic differences allows healthcare professionals to understand why certain people develop specific diseases or respond differently to treatments. By analyzing genetic data, doctors can identify disease risks at an early stage and provide treatments that are better suited to each patient. This approach supports more personalized healthcare, particularly in areas such as cancer treatment, rare disease diagnosis, and the selection of appropriate medications.

From a global perspective, the adoption of genomic medicine is expanding as governments promote national genome initiatives to improve healthcare outcomes. For instance, the Genomics England program, supported by the UK government, delivered the 100,000 Genomes Project, which sequenced more than 100,000 genomes from around 85,000 patients with rare diseases and cancers. These government-supported initiatives are strengthening genomic research infrastructure and accelerating the clinical integration of genomic technologies in modern healthcare systems.

Genomic Medicine Market- Market Dynamics

Growing adoption of precision medicine to accelerate market expansion

The increasing integration of precision medicine is contributing significantly to the advancement of the genomic medicine market. This approach emphasizes the development of treatment strategies that consider an individual's genetic characteristics, lifestyle patterns, and environmental influences. Progress in genomic sequencing and molecular diagnostic technologies allows healthcare professionals to gain deeper insights into disease pathways and select more appropriate therapeutic interventions. As healthcare providers increasingly adopt personalized treatment models, the demand for genomic analysis and genetic testing continues to expand. In addition, government-led genomic initiatives are supporting this transition toward individualized healthcare. For instance, the UK Department of Health and Social Care supports genomic programs through the NHS England Genomic Medicine Service, which performed over 800,000 genomic tests in 2023 to assist in diagnosing cancer and rare genetic disorders, reinforcing precision-based healthcare delivery.

In addition to government initiatives, biotechnology companies are expanding genomic technologies to support personalized medicine research and clinical adoption. For instance, BGI Genomics reported processing tens of millions of sequencing tests globally through its genomic platforms used in clinical diagnostics, reproductive health screening, and disease research. Such large-scale genomic testing capabilities support the identification of genetic variations and biomarkers, enabling healthcare providers and researchers to develop targeted therapies and individualized treatment strategies that reinforce the broader adoption of precision medicine.

Genomic Medicine Market- Segmentation Analysis:

The Global Genomic Medicine Market is segmented on the basis of Type, Application, Technology, Component, End User, and Region.

Based on Type, Diagnostic Genomic Medicine is likely to remain a key segment in the medicine market due to its critical role in identifying genetic variations associated with various diseases. The increasing adoption of genomic sequencing and molecular diagnostic technologies in healthcare systems has enhanced the ability of clinicians to detect genetic disorders, rare diseases, and cancer at an early stage. Diagnostic genomic tools also support more accurate clinical decision-making by enabling personalized treatment strategies. For instance, the NHS England established the NHS Genomic Medicine Service, which delivered over 810,000 genomic tests for patients in 2024, covering testing for more than 7,000 rare diseases and over 200 cancer indications. This expanding clinical application highlights the growing importance of diagnostic genomic medicine in improving early diagnosis and supporting precision healthcare strategies globally.

In terms of Component, this market is divided into three types: Instruments, Consumables and Software & Services. Consumables are predicted to account for a substantial portion of the market due to their continuous usage in sequencing and genomic testing workflows. Consumables such as reagents, sequencing kits, and flow cells are required for every genomic experiment or diagnostic test, creating recurring demand across laboratories and research institutions. For instance, Illumina reported that its sequencing consumables generated approximately $3.9 billion in revenue in 2023, reflecting the extensive use of reagents and kits in genomic research and clinical diagnostics. This consistent utilization highlights the importance of consumables in supporting large-scale genomic testing and precision medicine applications.

Genomic Medicine Market- Geographical Insights

The global genomic medicine market is experiencing steady expansion across several regions, supported by advancements in healthcare infrastructure, increased genomic research initiatives, and government policies encouraging precision medicine. Among these regions, North America continues to hold a significant position due to its strong institutional framework and sustained investments in genomic innovation. Government organizations and research institutions actively promote genomic sequencing, data integration, and personalized treatment approaches. For example, the National Institutes of Health introduced the All of Us Research Program, which aims to collect health and genetic information from over one million participants to support precision medicine research and improve individualized healthcare strategies.

Within North America, the United States plays a major role in advancing genomic medicine through both government and industry initiatives. According to the National Institutes of Health, genomic datasets from hundreds of thousands of participants have already been generated under national precision medicine initiatives, supporting disease research and therapeutic development. In addition, biotechnology companies such as Illumina and Thermo Fisher Scientific continue to expand genomic sequencing technologies and molecular diagnostic solutions. For example, Illumina has reported that its sequencing platforms have been used to generate the majority of the world's genomic data, supporting research laboratories, hospitals, and national genome projects worldwide. These government programs and industry developments collectively strengthen the United States' leadership and reinforce North America's influence in the global genomic medicine market.

Japan Genomic Medicine Market- Country Insights

In Japan, the genomic medicine market is steadily expanding due to strong government initiatives promoting precision healthcare and genomic research. The Ministry of Health, Labour and Welfare has supported nationwide genomic programs aimed at integrating genetic information into clinical practice, particularly in cancer diagnosis and treatment. In addition, the Japan Agency for Medical Research and Development (AMED) continues to fund large-scale genome research projects to improve disease prevention and personalized therapies, strengthening the country's genomic medicine ecosystem.

Japan has also implemented national genome initiatives such as the Initiative on Rare and Undiagnosed Diseases (IRUD), supported by AMED, to improve the diagnosis of rare genetic disorders. According to government program updates, the initiative has analyzed genomic data from tens of thousands of patients to support clinical diagnosis and research. Furthermore, the Japanese government continues to promote genomic data sharing and advanced medical research infrastructure, which is expected to enhance genomic medicine adoption and innovation within the country's healthcare system.

Genomic Medicine Market- Competitive Landscape:

Due to the continuous developments in genomic technologies and the increasing adoption of precision medicine, the global genomic medicine market is supported by the presence of both international biotechnology companies and emerging genomic solution providers, making it a extremely competitive industry. Companies offer their genomic platforms, sequencing technologies, and diagnostic solutions through direct sales channels, collaborations with healthcare institutions, research organizations, and pharmaceutical companies. Market participants compete on several factors including technological innovation, sequencing accuracy, data analysis capabilities, product reliability, and service availability. Key players such as Illumina, Thermo Fisher Scientific, F. Hoffmann-La Roche, QIAGEN, and Agilent Technologies are focusing on strategies such as new product development, expansion of genomic research capabilities, strategic partnerships, and acquisitions to strengthen their market presence and expand their role in advancing genomic-based healthcare solutions.

Recent Developments:

In December 2025, Illumina entered into a collaboration and strategic investment agreement with MyOme to advance genomic health modeling and large-scale clinical trials using whole-genome sequencing and AI-integrated risk models. The partnership aims to enhance early disease detection and preventive healthcare strategies.

In October 2025, Thermo Fisher Scientific entered a strategic co-marketing agreement with Genovation Health and XYGene to expand access to integrated genomic testing solutions. The collaboration integrates microarray-based genomic data with clinical decision-support tools to accelerate precision medicine and pharmacogenomics applications.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENOMIC MEDICINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • BGI Genomics
  • Illumina
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • QIAGEN
  • Agilent Technologies
  • BGI Genomics
  • Pacific Biosciences
  • Oxford Nanopore Technologies
  • Bio-Rad Laboratories
  • PerkinElmer
  • Myriad Genetics
  • Eurofins Scientific
  • Guardant Health
  • Natera
  • 23andMe, Inc.
  • Exact Sciences
  • Others

GLOBAL GENOMIC MEDICINE MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033

  • Predictive Genomic Medicine
  • Preventive Genomic Medicine
  • Diagnostic Genomic Medicine
  • Therapeutic Genomic Medicine

GLOBAL GENOMIC MEDICINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Oncology
  • Rare Genetic Diseases
  • Infectious Diseases
  • Pharmacogenomics
  • Others

GLOBAL GENOMIC MEDICINE MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033

  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Microarray
  • Gene Editing Technologies

GLOBAL GENOMIC MEDICINE MARKET, BY COMPONENT- MARKET ANALYSIS, 2020 - 2033

  • Instruments
  • Consumables
  • Software & Services
  • Others

GLOBAL GENOMIC MEDICINE MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • Pharmaceutical & Biotechnology Companies

GLOBAL GENOMIC MEDICINE MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Genomic Medicine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Genomic Medicine Market Snippet by Type
    • 2.1.2. Genomic Medicine Market Snippet by Application
    • 2.1.3. Genomic Medicine Market Snippet by Technology
    • 2.1.4. Genomic Medicine Market Snippet by Component
    • 2.1.5. Genomic Medicine Market Snippet by End User
    • 2.1.6. Genomic Medicine Market Snippet by Country
    • 2.1.7. Genomic Medicine Market Snippet by Region
  • 2.2. Competitive Insights

3. Genomic Medicine Key Market Trends

  • 3.1. Genomic Medicine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Genomic Medicine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Genomic Medicine Market Opportunities
  • 3.4. Genomic Medicine Market Future Trends

4. Genomic Medicine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Genomic Medicine Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Genomic Medicine Market Landscape

  • 6.1. Genomic Medicine Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Genomic Medicine Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
    • 7.1.2. Predictive Genomic Medicine
    • 7.1.3. Preventive Genomic Medicine
    • 7.1.4. Diagnostic Genomic Medicine
    • 7.1.5. Therapeutic Genomic Medicine

8. Genomic Medicine Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Oncology
    • 8.1.3. Rare Genetic Diseases
    • 8.1.4. Infectious Diseases
    • 8.1.5. Pharmacogenomics
    • 8.1.6. Others

9. Genomic Medicine Market - By Technology

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
    • 9.1.2. Next-Generation Sequencing (NGS)
    • 9.1.3. Polymerase Chain Reaction (PCR)
    • 9.1.4. Microarray
    • 9.1.5. Gene Editing Technologies

10. Genomic Medicine Market - By Component

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 10.1.2. Instruments
    • 10.1.3. Consumables
    • 10.1.4. Software & Services
    • 10.1.5. Others

11. Genomic Medicine Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 11.1.2. Hospitals & Clinics
    • 11.1.3. Diagnostic Laboratories
    • 11.1.4. Research Institutes
    • 11.1.5. Pharmaceutical & Biotechnology Companies

12. Genomic Medicine Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Genomic Medicine Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Genomic Medicine Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Genomic Medicine Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Genomic Medicine Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Genomic Medicine Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

13. Key Vendor Analysis- Genomic Medicine Industry

  • 13.1. Competitive Benchmarking
    • 13.1.1. Competitive Dashboard
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. BGI Genomics
    • 13.2.2. Illumina
    • 13.2.3. Thermo Fisher Scientific
    • 13.2.4. F. Hoffmann-La Roche
    • 13.2.5. QIAGEN
    • 13.2.6. Agilent Technologies
    • 13.2.7. BGI Genomics
    • 13.2.8. Pacific Biosciences
    • 13.2.9. Oxford Nanopore Technologies
    • 13.2.10. Bio-Rad Laboratories
    • 13.2.11. PerkinElmer
    • 13.2.12. Myriad Genetics
    • 13.2.13. Eurofins Scientific
    • 13.2.14. Guardant Health
    • 13.2.15. Natera
    • 13.2.16. 23andMe, Inc.
    • 13.2.17. Exact Sciences
    • 13.2.18. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제